1.Limited sequence variation in rhoptry protein 41 gene among Toxoplasma gondii isolates from different hosts and geographical locations
Tropical Biomedicine 2016;33(2):370-374
Toxoplasma gondii is a medically and agriculturally important protozoan parasite
that can infect virtually all the mammalian and avian species. Previous studies showed that
the family of rhoptry proteins (ROPs) plays a key role in the invasion process of T. gondii, and
its several members can be potential marker for population genetic researches of Toxoplasma.
In order to estimate whether other member is also suitable as the novel genetic marker, the
variation of ROP41 gene among 11 T. gondii isolates from different hosts and geographical
locations and two reference strains was examined in this study. Our results showed that all
the examined sequence of TgROP41 gene was 1473 bp in length, and their A+T contents
were between 48.47% and 48.88%. Sequence analysis presented 14 nucleotide mutation
positions (0%-0.54%), leading to 5 amino acid substitutions (0%-0.61%) through alignment with
T. gondii ME49 strain (ToxoDB: TGME49_266100). Furthermore, phylogenetic analyses by
MP and BI methods based on deduced amino acid sequences of TgROP41 gene was only able
to distinguish the type I strain, but not able to separate the two classical genotypes (Type II
and III) into the respective clusters. These results indicated limited sequence diversity in the
TgROP41 gene.
2.Investigations of clinical characteristics and inflammatory markers of febrile seizures induced by coronavirus infection
Zhao, L. ; Wu, H.Y. ; Xie, D. ; Mo, L.M. ; Yang, F.F. ; Gao, Y. ; Zhao, X.L. ; He, Y.Z.
Tropical Biomedicine 2023;40(No.4):439-443
The study of children who experienced with febrile seizures(FS) as a result of COVID-19 infection to gain
insight into the clinical characteristics and prognosis of neurological damage, with the aim of improving
prevention, diagnosis, and the treatment of neurological complications. This study investigated the
clinical features of 53 children with FS who were admitted to Sanya Women and Children’s Hospital
from December 1, 2022, to January 31, 2023. The results indicated that the duration of convulsion in
the case and control group was 7.90±8.91 and 2.67±1.23 (minutes) respectively. The analysis reveals
that convulsions occurred within 24 hours in 39 cases (95.12%) of the case group, and in 8 cases
(66.7%) of the control group. The difference was statistically significant (P<0.05). Additionally, the case
group presented lower counts of WBC and NEU compared to the control group (p<0.05). The findings
indicate that convulsions manifest at earlier stages of COVID-19 in children and the last longer than
in the control group. It is therefore crucial for healthcare workers to remain attentive to patients with
COVID-19 who report fever within 24 hours, and act promptly to implement preventive measures,
particularly in cases of prolonged fever. It is essential to integrate the clinical manifestation, particularly
convulsions, and the continuous numerical changes of inflammatory factors to assess COVID-19 linked
with febrile seizures. In addition, larger-scale multi-center and systematic research are necessary to
aid clinicians in monitoring neuropathological signals and biological targets, enabling more equitable
diagnosis and treatment plans.